Patent Assignment
Reel/Frame 041738/0041
Merger and Change of Name
Recorded: 2017-02-16
Pages: 6
Assignors
CELGENE AVILOMICS RESEARCH, INC.
Executed: 2016-12-23
CELGENE CAR LLC
Executed: 2016-12-23
Assignee
CELGENE CAR LLC
AON HOUSE, 30 WOODBOURNE AVENUE, PEMBROKE, HM 08, BERMUDA
Covered Properties
(55)
Hcv Protease Inhibitors and Uses Thereof
Hcv Protease Inhibitors and Uses Thereof
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
Hcv Protease Inhibitors and Uses Thereof
Hcv Protease Inhibitors and Uses Thereof
Hcv Protease Inhibitors and Uses Thereof
Methods for Identifying Hcv Protease Inhibitors
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
PI3 Kinase Inhibitors and Uses Thereof
Application:
12/878,965 →
Publication:
US 2011/0230476
Besylate Salt of a Btk Inhibitor
Heterocyclic Compounds and Uses Thereof
Heteroaryl Compounds and Uses Thereof
Mutant-Selective Egfr Inhibitors and Uses Thereof
Hcv Protease Inhibitors and Uses Thereof
Hcv Protease Inhibitors and Uses Thereof
Methods of Treating a Bruton's Tyrosine Kinase Disease or Disorder
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
2,4-Diaminopyrimidines Useful as Kinase Inhibitors
Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
Solid Forms of an Epidermal Growth Factor Receptor Kinase Inhibitor
Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
Hcv Protease Inhibitors and Uses Thereof
Methods of Treating a Disease or Disorder Associated with Bruton's Tyrosine Kinase
Application:
14/084,116 →
Publication:
US 2014/0142128
Methods of Treating a Disease or Disorder Associated with Bruton's Tyrosine Kinase
Application:
14/084,123 →
Publication:
US 2014/0140991
Methods of Treating a Disease or Disorder Associated with Bruton's Tyrosine Kinase
Application:
14/084,133 →
Publication:
US 2014/0142129
Methods of Treating a Disease or Disorder Associated with Bruton's Tyrosine Kinase
Application:
14/084,174 →
Publication:
US 2015/0064172
Methods of Treating a Disease or Disorder Associated with Bruton's Tyrosine Kinase
Methods of Treating a Disease or Disorder Associated with Bruton's Tyrosine Kinase
Application:
14/084,201 →
Publication:
US 2015/0139979
Heteroaryl Compounds and Uses Thereof
Heteroaryl Compounds and Uses Thereof
Erk Inhibitors and Uses Thereof
Heteroaryl Compounds and Uses Thereof
2,4-Disubstituted Pyrimidines as Kinase Inhibitors
Methods of Treating a Bruton's Tyrosine Kinase Disease or Disorder
Application:
14/425,499 →
Publication:
US 2015/0216865
Mutant-Selective Egfr Inhibitors and Uses Thereof
2,4-Disubstituted Pyrimidine Compounds Useful as Kinase Inhibtors
Hcv Protease Inhibitors and Uses Thereof
Solid Forms of an Epidermal Growth Factor Receptor Kinase Inhibitor
MK2 Inhibitors and Uses Thereof
Erk Inhibitors and Uses Thereof
Heteroaryl Compounds and Uses Thereof
Application:
14/774,208 →
Publication:
US 2016/0030426
Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
Heteroaryl Compounds and Uses Thereof
MK2 Inhibitors and Uses Thereof
Erk Inhibitors and Uses Thereof
Hcv Protease Inhibitors and Uses Thereof
Application:
14/887,092 →
Publication:
US 2016/0235805
Heteroaryl Compounds and Uses Thereof
Application:
14/957,761 →
Publication:
US 2016/0159774
Heteroaryl Compounds and Uses Thereof
Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
Heteroaryl Compounds and Uses Thereof
Methods of Treating a Bruton's Tyrosine Kinase Disease or Disorder
Application:
15/178,299 →
Publication:
US 2016/0287588
Heterocyclic Compounds and Uses Thereof
Hcv Protease Inhibitors and Uses Thereof
Application:
15/222,592 →
Publication:
US 2016/0326216
Mutant-Selective Egfr Inhibitors and Uses Thereof
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 26, 2009
From: NIU, DEQIANG; PETTER, RUSSELL C.; SINGH, JUSWINDER; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 022453/0929 →
Assignment of Assignor's Interest
Mar 26, 2009
From: PETTER, RUSSELL C.; SINGH, JUSWINDER; KLUGE, ARTHUR F.; NIU, DEQIANG
To: AVILA THERAPEUTICS, INC.
Reel/Frame 022456/0353 →
Assignment of Assignor's Interest
Sep 10, 2009
From: NIU, DEQIANG; PETTER, RUSSELL C.; SINGH, JUSWINDER; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 023214/0281 →
Assignment of Assignor's Interest
Sep 10, 2009
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 023213/0268 →
Assignment of Assignor's Interest
Sep 10, 2009
From: PETTER, RUSSELL C.; SINGH, JUSWINDER; KLUGE, ARTHUR F.; NIU, DEQIANG
To: AVILA THERAPEUTICS, INC.
Reel/Frame 023214/0318 →
Assignment of Assignor's Interest
Sep 29, 2009
From: NIU, DEQIANG; PETTER, RUSSELL C.; QIAO, LIXIN; SINGH, JUSWINDER
To: AVILA THERAPEUTICS, INC.
Reel/Frame 023296/0616 →
Assignment of Assignor's Interest
Oct 13, 2009
From: HAGEL, MARGIT; ST. MARTIN, THIA B.; NACHT, MARIANA S.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 023360/0732 →
Assignment of Assignor's Interest
Mar 26, 2010
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 024145/0455 →
Assignment of Assignor's Interest
Mar 11, 2011
From: NIU, DEQIANG; PETTER, RUSSELL C.; SINGH, JUSWINDER; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 025962/0973 →
Corrective Assignment to Correct the Application Number Needs to Be Updated to 12/878965 Previously Recorded on Reel 025962 Frame 0973. Assignor(S) Hereby Confirms the Originally Recorded as Application Number 12/878695.
May 24, 2011
From: NIU, DEQIANG; PETTER, RUSSELL C.; SINGH, JUSWINDER; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 026329/0157 →
Assignment of Assignor's Interest
Dec 19, 2011
From: WITOWSKI, STEVEN RICHARD; WESTLIN, WILLIAM FREDERICK, III; TESTER, RICHLAND WAYNE
To: AVILA THERAPEUTICS, INC.
Reel/Frame 027406/0884 →
Assignment of Assignor's Interest
Dec 20, 2011
From: LEE, KWANGHO; NIU, DEQIANG; PETTER, RUSSELL C.; BAEVSKY, MATTHEW FRANK
To: AVILA THERAPEUTICS, INC.
Reel/Frame 027417/0924 →
Assignment of Assignor's Interest
Dec 20, 2011
From: LEE, KWANGHO; NIU, DEQIANG; PETTER, RUSSELL C.; SINGH, JUSWINDER
To: AVILA THERAPEUTICS, INC.
Reel/Frame 027417/0939 →
Assignment of Assignor's Interest
Dec 20, 2011
From: LEE, KWANGHO; NIU, DEQIANG; BAEVSKY, MATTHEW FRANK
To: AVILA THERAPEUTICS, INC.
Reel/Frame 027417/0952 →
Assignment of Assignor's Interest
Aug 1, 2012
From: NIU, DEQIANG; PETTER, RUSSELL C.; QIAO, LIXIN; SINGH, JUSWINDER
To: AVILA THERAPEUTICS, INC.
Reel/Frame 028694/0979 →
Assignment of Assignor's Interest
Sep 27, 2012
From: NIU, DEQIANG; PETTER, RUSSELL C.; SINGH, JUSWINDER; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 029037/0018 →
Change of Name
Sep 28, 2012
From: AVILA THERAPEUTICS, INC.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029058/0066 →
Change of Name
Sep 28, 2012
From: AVILA THERAPEUTICS, INC.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029058/0058 →
Assignment of Assignor's Interest
Jan 29, 2013
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029715/0560 →
Assignment of Assignor's Interest
Feb 1, 2013
From: WITOWSKI, STEVEN RICHARD; WESTLIN, WILLIAM FREDERICK, III; LOUNSBURY, HEATHER; STIEDE, KATHRYN
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029740/0212 →
Nunc Pro Tunc Assignment
May 3, 2023
From: CELGENE CAR LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 063526/0959 →